SpyGlass Pharma (SGP) Assets Average (2025 - 2026)
SpyGlass Pharma (SGP) posted quarterly Assets Average of $69.6 million for Q4 2025.
SpyGlass Pharma (SGP) Assets Average (2025 - 2026) Analysis & Trends
SpyGlass Pharma (SGP) has reported Assets Average for 1 consecutive years, with $69.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average changed N/A year-over-year to $69.6 million; the TTM figure through Dec 2025 stood at $69.6 million (changed N/A YoY), while the FY2025 annual figure was $69.6 million, changed N/A from the prior year.
- Assets Average held at $69.6 million in Q4 2025 per SGP's latest filing.
- Across five years, Assets Average topped out at $69.6 million in Q4 2025 and bottomed at $69.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | SpyGlass Pharma | 876.29 Mn | 876.29 Mn | - | 179.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179.65 Mn |
| Dec 31, 2025 | 69.59 Mn |